SynthesisRheumatology international2025

Safety and efficacy of IL-17 inhibitors in patients with comorbid multiple sclerosis/multiple Sclerosis-like syndrome: a systematic review.

Nikolaos Chaitidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.